For the most part, we know how to mitigate the chronic diseases that plague people in their older years–eat healthily from early on, and get ple...
The chaotic inner life of cancer
(Continued from part I) Most people who’ve meet cancer on the battlefield of treatment, doctors or patients, come away with the impression of a robust...
Glucosamine: The new metformin? | Interview with Dr. Michael Ristow (part ii)
Last week when we heard from Dr. Ristow, he turned the outdated notion of the “free radical theory of aging” on its head, and demonstrated that antiox...
Cancer’s little helper
A menacing shadow looms large over the body. Lessons we’ve learned from the eternal struggle of organism against cell are etched into the farthest cor...
Free radicals are not your enemy | An interview with Dr. Michael Ristow (part i)
Dr. Michael Ristow, a professor of energy metabolism at ETH Zurich, bases much of his research into aging on a premise that many of us will find surpr...
James Peyer: Where are stem cell therapies headed?
Someday soon we may be able to replace tissues or entire organs with those grown from a patients’ own stem cells… but just how soon? What ...
James Peyer: Why primary indications matter
“Aging” isn’t a disease as recognized by the FDA–not yet anyway. But then how will the companies trialing anti-aging drugs eve...
Evolution: Pulling doubled lifespan out of a hat
Part III of III in a series on the evolution of aging. (Part I, Part II) If all you had to go on was our genomes, you’d surely conclude that humans an...
James Peyer: Navigating the “Biotech Valley of Death”
Ever hear about an exciting discovery in the biomedical world, then later wonder why it seemingly dropped off the face of the Earth? In fact, it’...
The Hallmarks of Aging: Loss of Proteostasis
Part of a series on the Hallmarks of Aging. Proteins don’t do everything in your body, but it’s fair to say they control everything. What they don’t d...